{
    "code": "02021236",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021236",
    "time": "2024-04-04 20:58:30",
    "許可證字號": "衛署藥輸字第021236號",
    "註銷狀態": "已註銷",
    "註銷日期": "113\/03\/06",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "115\/05\/15",
    "發證\/登錄日期": "110\/04\/20",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202123600",
    "中文品名": "&quot;加拿大廠&quot;卓弗蘭注射劑2毫克\/毫升",
    "英文品名": "ZOFRAN INJECTION 2MG\/ML",
    "適應症": "細胞毒性化學療法及放射線療法所致之噁心及嘔吐、以及手術引起之噁心、嘔吐",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 2、5毫升玻璃安瓿裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ONDANSETRON HYDROCHLORIDE DIHYDRATE",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "Sandoz Manufacturing Inc.",
            "製造廠廠址": "145 Jules Leger, Boucherville, Quebec, Canada, J4B 7K8",
            "製造廠公司地址": "",
            "製造廠國別": "CANADA",
            "製程": "成品製造、一級包裝、二級包裝"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "NOVARTIS PHARMA AG",
            "製造廠廠址": "LICHTSTRASSE 35 CH-4056 BASEL SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5622091212",
            "成分名稱": "ONDANSETRON HYDROCHLORIDE DIHYDRATE",
            "含量描述": "",
            "含量": "2.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "(附件四)_仿單_加拿大廠-卓弗蘭注射劑2毫克-毫升-TWI-301021-110-09-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021236&Seq=014&Type=9"
        },
        {
            "title": "Zofran _ 46297286_TW_LBL-110-10-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021236&Seq=011&Type=8"
        },
        {
            "title": "06.3_1883305_TW_p6_FB_X-4-110-10-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021236&Seq=010&Type=8"
        },
        {
            "title": "06.2_1883304_TW_p2_LBL_X-4-110-10-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021236&Seq=009&Type=8"
        },
        {
            "title": "06.1_1883302_TW_p7_FB_X-4-110-10-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021236&Seq=008&Type=8"
        },
        {
            "title": "10000000142560_TW_p1_FB_X-4-108-04-02(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021236&Seq=007&Type=8"
        }
    ]
}